We are live on
!
Find out more
M
Mirova Portfolio holdings
AUM
$2.46B
1-Year Est. Return
11.42%
This Fund
S&P 500
This Quarter
Est. Return
-8.83%
1 Year Est. Return
+11.42%
3 Year Est. Return
+32%
5 Year Est. Return
+23.08%
10 Year Est. Return
–
AUM
$497M
AUM Growth
-$71.5M
(-13%)
Cap. Flow
-$14.2M
Cap. Flow
% of AUM
-2.87%
Top 10 Holdings %
Top 10 Hldgs %
61.19%
Holding
163
New
–
Increased
30
Reduced
89
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trimble
TRMB
|
+$3.05M |
| 2 |
Tetra Tech
TTEK
|
+$2.94M |
| 3 |
IDEX
IEX
|
+$2.81M |
| 4 |
ANSS
Ansys
ANSS
|
+$2.32M |
| 5 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$2.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$6.63M |
| 2 |
Ecolab
ECL
|
+$3.95M |
| 3 |
NVIDIA
NVDA
|
+$3.04M |
| 4 |
Microsoft
MSFT
|
+$2.81M |
| 5 |
Mastercard
MA
|
+$2.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.8% |
| 2 | Healthcare | 26.71% |
| 3 | Industrials | 8.91% |
| 4 | Materials | 7.56% |
| 5 | Consumer Staples | 4.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Healthpeak Properties
DOC
$15.7B
| $42.2K | 0.01% |
2,301
-556
| -19% | -$11.4K |
|
127
A.O. Smith
AOS
$8.78B
| – | – |
-840
| Closed | -$61.1K |
|
128
Baxter International
BAX
$12.6B
| – | – |
-1,275
| Closed | -$58.1K |
|
129
Becton Dickinson
BDX
$45.4B
| – | – |
-676
| Closed | -$178K |
|
130
Boston Scientific
BSX
$69.1B
| – | – |
-3,269
| Closed | -$177K |
|
131
Boston Properties
BXP
$11.1B
| – | – |
-1,369
| Closed | -$78.8K |
|
132
Charles River Laboratories
CRL
$11.4B
| – | – |
-115
| Closed | -$24.2K |
|
133
Quest Diagnostics
DGX
$26.1B
| – | – |
-268
| Closed | -$37.7K |
|
134
DaVita
DVA
$15.5B
| – | – |
-194
| Closed | -$19.5K |
|
135
Essex Property Trust
ESS
$19B
| – | – |
-549
| Closed | -$129K |
|
136
Fortinet
FTNT
$111B
| – | – |
-2,681
| Closed | -$203K |
|
137
Gilead Sciences
GILD
$166B
| – | – |
-2,168
| Closed | -$167K |
|
138
Globe Life
GL
$13.9B
| – | – |
-437
| Closed | -$47.9K |
|
|
HOLX
139
DELISTED
Hologic
HOLX
| – | – |
-766
| Closed | -$62K |
|
140
Henry Schein
HSIC
$9.75B
| – | – |
-300
| Closed | -$24.3K |
|
141
Illumina
ILMN
$29.1B
| – | – |
-289
| Closed | -$52.7K |
|
142
International Paper
IP
$23.2B
| – | – |
-15,196
| Closed | -$483K |
|
143
IQVIA
IQV
$39.9B
| – | – |
-308
| Closed | -$69.2K |
|
144
Labcorp
LH
$25.5B
| – | – |
-268
| Closed | -$55.5K |
|
145
Lumen
LUMN
$6.26B
| – | – |
-62,440
| Closed | -$141K |
|
146
Masco
MAS
$16.5B
| – | – |
-11,847
| Closed | -$680K |
|
147
Molina Healthcare
MOH
$10.4B
| – | – |
-167
| Closed | -$50.3K |
|
148
Mettler-Toledo International
MTD
$27.9B
| – | – |
-42
| Closed | -$55.1K |
|
149
Organon & Co
OGN
$3.56B
| – | – |
-473
| Closed | -$9.84K |
|
150
Paycom
PAYC
$7.57B
| – | – |
-202
| Closed | -$64.9K |
|
Similar funds
BW
SCM
GWM
TW
JC
SG
RL
QT
Mirova's Q3 2023 Portfolio in Review
As of Q3 2023, Mirova held 163 positions worth $497M, down 13% from $568M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Mirova's Q3 2023 filing shows 30 increased, 89 reduced and 37 closed positions. The largest sale was Thermo Fisher Scientific, an estimated $6.63M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 40% a quarter earlier, followed by Healthcare and Industrials.
- Mirova added most to Trimble in Q3 2023, an estimated $3.05M increase.
- Mirova's biggest Q3 2023 reduction was Thermo Fisher Scientific, cutting an estimated $6.63M.
- Mirova fully exited Masco in Q3 2023, selling an estimated $680K.
- Mirova's ten largest holdings make up 61% of its $497M portfolio in Q3 2023.
- Mirova opened 0 new positions and closed 37 in Q3 2023.
- Mirova's portfolio value fell 13% quarter-over-quarter to $497M.
Based on Mirova's 13F filing for Q3 2023, filed 14 Nov 2023.